Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30862 | 131 | 37.7 | 33% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
165 | 21626 | PARKINSONS DISEASE//DEEP BRAIN STIMULATION//MOVEMENT DISORDERS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AMINE ACCUMULATION | Author keyword | 2 | 67% | 2% | 2 |
2 | CATIONIZED POLYACRYLAMIDE | Author keyword | 2 | 67% | 2% | 2 |
3 | LONG TERM DEFICITS | Author keyword | 1 | 50% | 1% | 1 |
4 | MAZOWIECKI SZPITAL BRODNOWSKI | Address | 1 | 50% | 1% | 1 |
5 | COLIBAN MED | Address | 0 | 33% | 1% | 1 |
6 | TUBEROINFUNDIBULAR DOPAMINERGIC SYSTEM | Author keyword | 0 | 33% | 1% | 1 |
7 | BRONOWSKI BEHAV NEUROSCI | Address | 0 | 18% | 2% | 2 |
8 | LAVRENTEV NEUROHISTOL | Address | 0 | 25% | 1% | 1 |
9 | RECOGNITION PEPTIDE | Author keyword | 0 | 25% | 1% | 1 |
10 | MELATONIN ANTAGONIST | Author keyword | 0 | 17% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AMINE ACCUMULATION | 2 | 67% | 2% | 2 | Search AMINE+ACCUMULATION | Search AMINE+ACCUMULATION |
2 | CATIONIZED POLYACRYLAMIDE | 2 | 67% | 2% | 2 | Search CATIONIZED+POLYACRYLAMIDE | Search CATIONIZED+POLYACRYLAMIDE |
3 | LONG TERM DEFICITS | 1 | 50% | 1% | 1 | Search LONG+TERM+DEFICITS | Search LONG+TERM+DEFICITS |
4 | TUBEROINFUNDIBULAR DOPAMINERGIC SYSTEM | 0 | 33% | 1% | 1 | Search TUBEROINFUNDIBULAR+DOPAMINERGIC+SYSTEM | Search TUBEROINFUNDIBULAR+DOPAMINERGIC+SYSTEM |
5 | RECOGNITION PEPTIDE | 0 | 25% | 1% | 1 | Search RECOGNITION+PEPTIDE | Search RECOGNITION+PEPTIDE |
6 | MELATONIN ANTAGONIST | 0 | 17% | 1% | 1 | Search MELATONIN+ANTAGONIST | Search MELATONIN+ANTAGONIST |
7 | BEHAVIORAL SUPERSENSITIVITY | 0 | 11% | 1% | 1 | Search BEHAVIORAL+SUPERSENSITIVITY | Search BEHAVIORAL+SUPERSENSITIVITY |
8 | IGF BP3 | 0 | 11% | 1% | 1 | Search IGF+BP3 | Search IGF+BP3 |
9 | ANGIODYNAMICS | 0 | 100% | 1% | 1 | Search ANGIODYNAMICS | Search ANGIODYNAMICS |
10 | ATENALOL | 0 | 100% | 1% | 1 | Search ATENALOL | Search ATENALOL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AMINE ACCUMULATION | 6 | 80% | 3% | 4 |
2 | ACID MONOAMINE METABOLITES | 1 | 50% | 1% | 1 |
3 | BEHAVIORAL PATHOLOGY | 1 | 50% | 1% | 1 |
4 | PROLACTIN INDUCED ACTIVATION | 1 | 50% | 1% | 1 |
5 | DECARBOXYLASE INHIBITORS | 0 | 11% | 1% | 1 |
6 | MONO AMINES | 0 | 11% | 1% | 1 |
7 | MACACA FASICULARIS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
AMINE ACCUMULATION IN PARKINSONS-DISEASE AND OTHER DISORDERS | 1987 | 74 | 47 | 32% |
Acute levodopa intake and associated cortisol decrease in patients with Parkinson disease | 2007 | 9 | 19 | 21% |
Dynamics of tumour angiogenesis: Effect of razoxane-induced growth rate slowdown | 2003 | 13 | 18 | 28% |
RAZOXANE - A REVIEW OF 6 YEARS THERAPY IN PSORIASIS | 1983 | 13 | 2 | 50% |
ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL SURGERY FOR CANCER OF THE LARGE BOWEL | 1985 | 0 | 3 | 67% |
A ROLE FOR AMINE ACCUMULATION IN THE SYNDROME OF INGESTIVE DEFICITS FOLLOWING LATERAL HYPOTHALAMIC-LESIONS | 1984 | 7 | 20 | 40% |
AMINE ACCUMULATION IN BEHAVIORAL PATHOLOGY | 1985 | 8 | 30 | 33% |
NORMAL REPRODUCTIVE DEVELOPMENT IN THE ADOLESCENT FEMALE | 1986 | 1 | 6 | 17% |
LOW T3-T4-TSH SYNDROME - A MULTIFACTORIAL ASSOCIATION | 1983 | 1 | 5 | 20% |
Reversal of an acute parkinsonian syndrome associated with multiple sclerosis by application of weak electromagnetic fields | 1996 | 6 | 51 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAZOWIECKI SZPITAL BRODNOWSKI | 1 | 50% | 0.8% | 1 |
2 | COLIBAN MED | 0 | 33% | 0.8% | 1 |
3 | BRONOWSKI BEHAV NEUROSCI | 0 | 18% | 1.5% | 2 |
4 | LAVRENTEV NEUROHISTOL | 0 | 25% | 0.8% | 1 |
5 | PERINATAL PATHOL UNIT | 0 | 11% | 0.8% | 1 |
6 | HADASSAH MT | 0 | 100% | 0.8% | 1 |
7 | MEDNEUROVASC MED PICKERING UNIT | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000175505 | 3RD MESSENGER//LEARNED HELPLESSNESS BEHAVIOR//MARKER ENZYME |
2 | 0.0000159969 | CHRONIC BILATERAL SUBTHALAMIC STIMULATION//ACOUSTIC BLINK REFLEX//FAMILY INTERNAL MED |
3 | 0.0000141230 | TERGURIDE//ERGOLINE//DOPAMINE D 2 AGONIST |
4 | 0.0000139450 | LOSS OF NEURONS//SOMATOSTATIN LIKE IMMUNOREACTIVITY//VASCULAR DEMENTIA OF THE BINSWANGER TYPE |
5 | 0.0000105519 | PROBIMANE//BIMOLANE//BISDIOXOPIPERAZINE COMPOUNDS |
6 | 0.0000103192 | NEONATAL 6 HYDROXYDOPAMINE//SUPERSENSITIZATION//PPE MESSENGER RNA |
7 | 0.0000083479 | CARDIOVASCULAR DYSAUTONOMIA//ANF//CARDIAC SYMPATHETIC DENERVATION |
8 | 0.0000081475 | C18L GENE//GO GENE ONTOLOGY//KEGG KYOTO ENCYCLOPEDIA OF GENES AND GENOMES |
9 | 0.0000081001 | HEMOPOESIS//ANTIGEN SPECIFIC PROLIFERATION//COLONY FORMING ACTIVITY |
10 | 0.0000072384 | NEUROIMMUNOPATHOL//DEPRESSIVE SYNDROME//PARLODEL |